Skip to main content

PUKO Nutrition Launches Focus + Drive: A Two-Speed Nootropic for Clean Energy Now and Brain Support That Builds Over Weeks

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

-- PUKO Nutrition, a U.S. direct-to-consumer company focused on cognitive performance, today announced the nationwide launch of PUKO Focus + Drive, a daily nootropic supplement designed to support mental energy on two timelines: within the hour, and over the weeks that follow. It is the first stage of a three-part system that treats daytime focus and nighttime recovery as two halves of the same cognitive engine.

The flagship pairs slow-release guarana with clinically studied phosphatidylserine at fully disclosed doses to support mental energy through the workday. Two melatonin-free night formulas carry the same system into sleep, the brain's window for recovery and long-term nutrition.

Focus + Drive takes a different route. Each two-capsule serving pairs 200 mg of guarana extract, a plant caffeine source whose gradual release comes from caffeine naturally bound to tannins and fiber, with 60 mg of phosphatidylserine, a structural phospholipid of brain cell membranes that supports healthy cognitive function and brain cell communication.The guarana supports alertness and reaction time within 30 to 60 minutes, while the phosphatidylserine builds cognitive support over four to six weeks of consistent daily use.* Both doses are printed in full on the label, with no proprietary blends and no synthetic caffeine.

"Most energy products sell a stronger hit. We built a base that compounds," the company said in a statement. "Guarana gives you clean mental energy this afternoon, and phosphatidylserine supports memory and attention over weeks of daily use.* Energy is the entry point. Thinking performance is the goal."

The second stage of the system is sleep, and PUKO approaches it as brain infrastructure rather than a separate category. During deep, slow-wave sleep the brain naturally consolidates the day's learning into memory and clears the metabolic byproducts of a full day of thinking. That is why the CDC's finding that more than one in three U.S. adults does not get enough sleep is as much a performance problem as a health one.PUKO's two night formulas support that overnight window without synthetic melatonin. PUKO Unwind + Sleep KSM-66 combines 240 mg of magnesium glycinate chelate, 200 mg of KSM-66® ashwagandha extract standardized to 5% withanolides, and 150 mg of lemon balm extract to support evening wind-down and the body's response to everyday stress.* PUKO Deep Sleep + Recovery pairs 240 mg of magnesium glycinate chelate with Montmorency tart cherry powder, a natural source of melatonin precursors, and saffron extract to support deep, restorative sleep and long-term brain nutrition through consistent overnight recovery.* Both are non-habit forming.

"Better sleep is the most underrated layer of cognitive performance," the company added. "The daytime capsule supports the hours you spend thinking. The night formulas support the hours your brain uses to consolidate what you learned and restock for tomorrow. That is why we built them as one staged system instead of separate products."

The full system is available now at pukonutrition.com.

ABOUT PUKO NUTRITION

PUKO Nutrition is a U.S. direct-to-consumer supplement company founded in 2022. Its staged three-formula system supports daytime focus and deep, restorative sleep as the foundation of long-term cognitive performance. All formulas are non-habit forming and third-party tested, the sleep formulas contain no synthetic melatonin, and every label discloses the exact dose of every active ingredient. Learn more at https://pukonutrition.com.

Contact Info:
Name: Daniel Fan
Email: Send Email
Organization: PUKO Nutrition
Website: https://pukonutrition.com/

Release ID: 89198300

Should there be any problems, inaccuracies, or doubts arising from the content provided in this press release that require attention or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is central to our commitment.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  243.71
-3.84 (-1.55%)
AAPL  324.73
-3.01 (-0.92%)
AMD  555.76
+11.33 (2.08%)
BAC  61.82
+0.60 (0.98%)
GOOG  346.73
+0.54 (0.15%)
META  628.77
-15.03 (-2.34%)
MSFT  389.15
-8.60 (-2.16%)
NVDA  213.45
+6.16 (2.97%)
ORCL  126.00
-1.05 (-0.83%)
TSLA  378.36
-0.57 (-0.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.